Opiant Pharmaceuticals is a biotechnology business based in the US. Opiant Pharmaceuticals shares (OPNT) are listed on the NASDAQ and all prices are listed in US Dollars. Opiant Pharmaceuticals employs 37 staff and has a trailing 12-month revenue of around $22.3 million.
Our top picks for where to buy Opiant Pharmaceuticals stock
How to buy Opiant Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – OPNT. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Opiant Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Opiant Pharmaceuticals stock price (NASDAQ: OPNT)
Use our graph to track the performance of OPNT stocks over time.Opiant Pharmaceuticals shares at a glance
Latest market close | $20.65 |
---|---|
52-week range | $0.00 - $0.00 |
50-day moving average | $20.50 |
200-day moving average | $14.79 |
Wall St. target price | $21.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-6.53 |
Is it a good time to buy Opiant Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Opiant Pharmaceuticals price performance over time
Historical closes compared with the close of $20.65 from 2023-03-02
1 week (2024-08-26) | N/A |
---|---|
1 month (2024-08-02) | N/A |
3 months (2024-06-02) | N/A |
6 months (2024-03-02) | N/A |
1 year (2023-09-02) | N/A |
---|---|
2 years (2022-09-06) | 86.04% |
3 years (2021-09-03) | 13.84% |
5 years (2019-09-06) | 51.84% |
Opiant Pharmaceuticals financials
Revenue TTM | $22.3 million |
---|---|
Gross profit TTM | $21.9 million |
Return on assets TTM | -35.51% |
Return on equity TTM | -105.87% |
Profit margin | -148.13% |
Book value | $3.97 |
Market Capitalization | $108.8 million |
TTM: trailing 12 months
Opiant Pharmaceuticals share dividends
We're not expecting Opiant Pharmaceuticals to pay a dividend over the next 12 months.
Have Opiant Pharmaceuticals's shares ever split?
Opiant Pharmaceuticals's shares were split on a 1:100 basis on 30 December 2014. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Opiant Pharmaceuticals shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for Opiant Pharmaceuticals shares which in turn could have impacted Opiant Pharmaceuticals's share price.
Opiant Pharmaceuticals share price volatility
Over the last 12 months, Opiant Pharmaceuticals's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Opiant Pharmaceuticals's is 0.8316. This would suggest that Opiant Pharmaceuticals's shares are less volatile than average (for this exchange).
Opiant Pharmaceuticals overview
Opiant Pharmaceuticals, Inc. , a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016.
Frequently asked questions
What percentage of Opiant Pharmaceuticals is owned by insiders or institutions?Currently 7.635% of Opiant Pharmaceuticals shares are held by insiders and 41.998% by institutions. How many people work for Opiant Pharmaceuticals?
Latest data suggests 37 work at Opiant Pharmaceuticals. When does the fiscal year end for Opiant Pharmaceuticals?
Opiant Pharmaceuticals's fiscal year ends in July. Where is Opiant Pharmaceuticals based?
Opiant Pharmaceuticals's address is: 233 Wilshirre Boulevard, Santa Monica, CA, United States, 90401 What is Opiant Pharmaceuticals's ISIN number?
Opiant Pharmaceuticals's international securities identification number is: US6837501039 What is Opiant Pharmaceuticals's CUSIP number?
Opiant Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 53224T105
More guides on Finder
-
How to buy Zentek stock (ZTEK)
Steps to owning and managing ZTEK, with 24-hour and historical pricing before you buy.
-
How to buy Mainz Biomed stock (Mainz Biomed)
Steps to owning and managing MYNZ, with 24-hour and historical pricing before you buy.
-
How to buy ATAI Life Sciences stock (Atai Life Sciences)
Steps to owning and managing ATAI, with 24-hour and historical pricing before you buy.
-
How to buy Owlet Baby Care stock (Owlet Baby Care)
Steps to owning and managing OWLT, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Humana stock (HUM)
Steps to owning and managing HUM, with 24-hour and historical pricing before you buy.
-
How to buy Illumina stock (ILMN)
Steps to owning and managing ILMN, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question